

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.17249753 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.17249753 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.93852766 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.93852766 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.58909874 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 6.37155346 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.22711527 |
| 8 | high-density lipoprotein particle remodeling (GO:0034375) | 5.60491547 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.39320229 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.39320229 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.39320229 |
| 12 | urea cycle (GO:0000050) | 5.38267587 |
| 13 | urea metabolic process (GO:0019627) | 5.38267587 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.25958343 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.25669255 |
| 16 | regulation of cholesterol esterification (GO:0010872) | 5.24872131 |
| 17 | regulation of triglyceride catabolic process (GO:0010896) | 5.15950331 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.15636818 |
| 19 | bile acid biosynthetic process (GO:0006699) | 5.15205299 |
| 20 | cysteine metabolic process (GO:0006534) | 5.14823011 |
| 21 | phenylpropanoid metabolic process (GO:0009698) | 5.09390862 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 5.07454428 |
| 23 | reverse cholesterol transport (GO:0043691) | 5.06636509 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.06023885 |
| 25 | omega-hydroxylase P450 pathway (GO:0097267) | 5.05201672 |
| 26 | phospholipid efflux (GO:0033700) | 5.01669323 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.95813780 |
| 28 | intestinal cholesterol absorption (GO:0030299) | 4.90582515 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 4.82707302 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.81129307 |
| 31 | protein carboxylation (GO:0018214) | 4.81129307 |
| 32 | plasma lipoprotein particle remodeling (GO:0034369) | 4.79438968 |
| 33 | protein-lipid complex remodeling (GO:0034368) | 4.79438968 |
| 34 | macromolecular complex remodeling (GO:0034367) | 4.79438968 |
| 35 | homocysteine metabolic process (GO:0050667) | 4.74602930 |
| 36 | negative regulation of sterol transport (GO:0032372) | 4.72752818 |
| 37 | negative regulation of cholesterol transport (GO:0032375) | 4.72752818 |
| 38 | acylglycerol homeostasis (GO:0055090) | 4.66189527 |
| 39 | triglyceride homeostasis (GO:0070328) | 4.66189527 |
| 40 | serine family amino acid catabolic process (GO:0009071) | 4.66151305 |
| 41 | regulation of fibrinolysis (GO:0051917) | 4.63306785 |
| 42 | bile acid metabolic process (GO:0008206) | 4.63260177 |
| 43 | blood coagulation, intrinsic pathway (GO:0007597) | 4.60303195 |
| 44 | aromatic amino acid family metabolic process (GO:0009072) | 4.59189980 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.52605243 |
| 46 | cholesterol efflux (GO:0033344) | 4.50536481 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.47074474 |
| 48 | complement activation, alternative pathway (GO:0006957) | 4.44189547 |
| 49 | drug catabolic process (GO:0042737) | 4.43087075 |
| 50 | regulation of protein activation cascade (GO:2000257) | 4.40777144 |
| 51 | lysine metabolic process (GO:0006553) | 4.40775297 |
| 52 | lysine catabolic process (GO:0006554) | 4.40775297 |
| 53 | plasma lipoprotein particle assembly (GO:0034377) | 4.39132969 |
| 54 | ethanol oxidation (GO:0006069) | 4.33644053 |
| 55 | bile acid and bile salt transport (GO:0015721) | 4.33310968 |
| 56 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.33240532 |
| 57 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.33240532 |
| 58 | amino-acid betaine metabolic process (GO:0006577) | 4.30948082 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 4.28015842 |
| 60 | alpha-amino acid catabolic process (GO:1901606) | 4.21122950 |
| 61 | intestinal absorption (GO:0050892) | 4.20517580 |
| 62 | regulation of bile acid biosynthetic process (GO:0070857) | 4.17900777 |
| 63 | negative regulation of protein activation cascade (GO:2000258) | 4.16884791 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 4.14193678 |
| 65 | regulation of complement activation (GO:0030449) | 4.08429115 |
| 66 | regulation of plasminogen activation (GO:0010755) | 4.05963352 |
| 67 | fructose metabolic process (GO:0006000) | 3.97951745 |
| 68 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.96651811 |
| 69 | flavonoid metabolic process (GO:0009812) | 3.95738149 |
| 70 | regulation of cholesterol homeostasis (GO:2000188) | 3.94083147 |
| 71 | protein-lipid complex assembly (GO:0065005) | 3.93854153 |
| 72 | oxidative demethylation (GO:0070989) | 3.93843753 |
| 73 | acute-phase response (GO:0006953) | 3.93830694 |
| 74 | lipoprotein metabolic process (GO:0042157) | 3.93757970 |
| 75 | cellular amino acid catabolic process (GO:0009063) | 3.93619771 |
| 76 | cellular modified amino acid catabolic process (GO:0042219) | 3.92584630 |
| 77 | indolalkylamine metabolic process (GO:0006586) | 3.91849315 |
| 78 | glutamate metabolic process (GO:0006536) | 3.90257542 |
| 79 | heme transport (GO:0015886) | 3.90157852 |
| 80 | cholesterol homeostasis (GO:0042632) | 3.89725144 |
| 81 | coenzyme catabolic process (GO:0009109) | 3.87257488 |
| 82 | cellular glucuronidation (GO:0052695) | 3.86524414 |
| 83 | negative regulation of hemostasis (GO:1900047) | 3.86258430 |
| 84 | negative regulation of blood coagulation (GO:0030195) | 3.86258430 |
| 85 | sterol homeostasis (GO:0055092) | 3.84102983 |
| 86 | glycine metabolic process (GO:0006544) | 3.79570879 |
| 87 | arginine metabolic process (GO:0006525) | 3.78951007 |
| 88 | plasma lipoprotein particle organization (GO:0071827) | 3.76492895 |
| 89 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.76115903 |
| 90 | serine family amino acid metabolic process (GO:0009069) | 3.76071264 |
| 91 | benzene-containing compound metabolic process (GO:0042537) | 3.72788537 |
| 92 | cellular biogenic amine catabolic process (GO:0042402) | 3.71600710 |
| 93 | amine catabolic process (GO:0009310) | 3.71600710 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 3.69641920 |
| 95 | ketone body metabolic process (GO:1902224) | 3.68817354 |
| 96 | drug transmembrane transport (GO:0006855) | 3.67607686 |
| 97 | phospholipid homeostasis (GO:0055091) | 3.66545450 |
| 98 | imidazole-containing compound metabolic process (GO:0052803) | 3.64271887 |
| 99 | doxorubicin metabolic process (GO:0044598) | 3.61962988 |
| 100 | daunorubicin metabolic process (GO:0044597) | 3.61962988 |
| 101 | polyketide metabolic process (GO:0030638) | 3.61962988 |
| 102 | negative regulation of complement activation (GO:0045916) | 3.61686162 |
| 103 | negative regulation of coagulation (GO:0050819) | 3.61146846 |
| 104 | ethanol metabolic process (GO:0006067) | 3.61091175 |
| 105 | drug metabolic process (GO:0017144) | 3.60206614 |
| 106 | protein activation cascade (GO:0072376) | 3.59078104 |
| 107 | xenobiotic catabolic process (GO:0042178) | 3.58123240 |
| 108 | negative regulation of wound healing (GO:0061045) | 3.56034920 |
| 109 | negative regulation of lipase activity (GO:0060192) | 3.54338065 |
| 110 | protein-lipid complex subunit organization (GO:0071825) | 3.54243264 |
| 111 | exogenous drug catabolic process (GO:0042738) | 3.53233630 |
| 112 | carboxylic acid catabolic process (GO:0046395) | 3.51965416 |
| 113 | organic acid catabolic process (GO:0016054) | 3.51965416 |
| 114 | serine family amino acid biosynthetic process (GO:0009070) | 3.51884962 |
| 115 | low-density lipoprotein particle remodeling (GO:0034374) | 3.50479489 |
| 116 | aldehyde catabolic process (GO:0046185) | 3.49559583 |
| 117 | glucuronate metabolic process (GO:0019585) | 3.45963066 |
| 118 | uronic acid metabolic process (GO:0006063) | 3.45963066 |
| 119 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.45473023 |
| 120 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.45271120 |
| 121 | short-chain fatty acid metabolic process (GO:0046459) | 3.43846530 |
| 122 | fibrinolysis (GO:0042730) | 3.42050381 |
| 123 | alkaloid metabolic process (GO:0009820) | 3.41317911 |
| 124 | complement activation, classical pathway (GO:0006958) | 3.39053247 |
| 125 | proline metabolic process (GO:0006560) | 3.38641633 |
| 126 | hormone catabolic process (GO:0042447) | 3.37634667 |
| 127 | urate metabolic process (GO:0046415) | 3.36205867 |
| 128 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.28987214 |
| 129 | L-ascorbic acid metabolic process (GO:0019852) | 3.26132900 |
| 130 | regulation of humoral immune response (GO:0002920) | 3.25628273 |
| 131 | complement activation (GO:0006956) | 3.23397467 |
| 132 | NADH metabolic process (GO:0006734) | 3.19242889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.03887962 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.98077938 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.47483214 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.29613121 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.96927658 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.91859834 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.55373123 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.83187322 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.77995472 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.53902194 |
| 11 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.51662290 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.04874745 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2574747 |
| 14 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.94106194 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93638911 |
| 16 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.72893617 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.69185975 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.66965166 |
| 19 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64685028 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.57712828 |
| 21 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.55790861 |
| 22 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.44127082 |
| 23 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.39811722 |
| 24 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33281701 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.33277241 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25579818 |
| 27 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.19569192 |
| 28 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.19019960 |
| 29 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.18752275 |
| 30 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12365790 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10859880 |
| 32 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.09534088 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.09197476 |
| 34 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.03960261 |
| 35 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02540592 |
| 36 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00446701 |
| 37 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.96465475 |
| 38 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95739874 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95675798 |
| 40 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95279804 |
| 41 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.94767798 |
| 42 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92662074 |
| 43 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92390621 |
| 44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.90562432 |
| 45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88654371 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.87764733 |
| 47 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.85594028 |
| 48 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.84520229 |
| 49 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.84359030 |
| 50 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.83875999 |
| 51 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.83437392 |
| 52 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.83437392 |
| 53 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.83107807 |
| 54 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83029478 |
| 55 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81464817 |
| 56 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80549701 |
| 57 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.79955824 |
| 58 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.79628138 |
| 59 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79152618 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.77726596 |
| 61 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77312116 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.77268119 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.75409919 |
| 64 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.74645263 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.73116093 |
| 66 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.73008012 |
| 67 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.72184550 |
| 68 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.69624182 |
| 69 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.69285752 |
| 70 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.69136551 |
| 71 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.68980930 |
| 72 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.68908048 |
| 73 | NCOR_22424771_ChIP-Seq_293T_Human | 0.68624489 |
| 74 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.68312457 |
| 75 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.68022547 |
| 76 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.67776520 |
| 77 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.67565115 |
| 78 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67475086 |
| 79 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.67373782 |
| 80 | AR_20517297_ChIP-Seq_VCAP_Human | 0.66421305 |
| 81 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.66107390 |
| 82 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.66101427 |
| 83 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65645666 |
| 84 | * GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.65560270 |
| 85 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.65485664 |
| 86 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.64441307 |
| 87 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.64140285 |
| 88 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.63954996 |
| 89 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62776406 |
| 90 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.61971250 |
| 91 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61896468 |
| 92 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.61751317 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.61109180 |
| 94 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.60711158 |
| 95 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.60573893 |
| 96 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.60473275 |
| 97 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.59796620 |
| 98 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.59791656 |
| 99 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.59749279 |
| 100 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.59647008 |
| 101 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.59502394 |
| 102 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.58618448 |
| 103 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.57585931 |
| 104 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.57585931 |
| 105 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.57221939 |
| 106 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.57015957 |
| 107 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.56348226 |
| 108 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56274387 |
| 109 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.55118423 |
| 110 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.54435524 |
| 111 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.53772956 |
| 112 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.53699550 |
| 113 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53675517 |
| 114 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.53295711 |
| 115 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.53245651 |
| 116 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.52538419 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.52492129 |
| 118 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.51459190 |
| 119 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.51244739 |
| 120 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.51233643 |
| 121 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51021905 |
| 122 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.50697914 |
| 123 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.50502819 |
| 124 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.50417982 |
| 125 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49366687 |
| 126 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.48977543 |
| 127 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.48560906 |
| 128 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47558522 |
| 129 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45412512 |
| 130 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.44033711 |
| 131 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.44025030 |
| 132 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.43909173 |
| 133 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43481935 |
| 134 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.43375890 |
| 135 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.42462603 |
| 136 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41357785 |
| 137 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.41283143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.05032318 |
| 2 | MP0005360_urolithiasis | 7.88436255 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.01145207 |
| 4 | MP0005365_abnormal_bile_salt | 5.72194172 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.84636885 |
| 6 | MP0003252_abnormal_bile_duct | 3.99882907 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.66838813 |
| 8 | MP0009840_abnormal_foam_cell | 3.52745452 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.47267925 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.45165685 |
| 11 | MP0003195_calcinosis | 2.87184079 |
| 12 | MP0005332_abnormal_amino_acid | 2.77952091 |
| 13 | MP0005083_abnormal_biliary_tract | 2.47597135 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.43156246 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.31355448 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.20793231 |
| 17 | MP0000609_abnormal_liver_physiology | 2.04166597 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.03530090 |
| 19 | MP0003868_abnormal_feces_composition | 1.93638526 |
| 20 | MP0001764_abnormal_homeostasis | 1.79945000 |
| 21 | MP0009697_abnormal_copulation | 1.72632549 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.69062928 |
| 23 | MP0009643_abnormal_urine_homeostasis | 1.59403566 |
| 24 | MP0005451_abnormal_body_composition | 1.43070792 |
| 25 | MP0003879_abnormal_hair_cell | 1.38389091 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.36140054 |
| 27 | MP0005084_abnormal_gallbladder_morpholo | 1.26394712 |
| 28 | MP0003122_maternal_imprinting | 1.26092448 |
| 29 | MP0005636_abnormal_mineral_homeostasis | 1.21585560 |
| 30 | MP0004043_abnormal_pH_regulation | 1.17898214 |
| 31 | MP0000566_synostosis | 1.10798463 |
| 32 | MP0005220_abnormal_exocrine_pancreas | 1.10084620 |
| 33 | MP0004264_abnormal_extraembryonic_tissu | 1.07052015 |
| 34 | MP0003186_abnormal_redox_activity | 1.06434736 |
| 35 | MP0000598_abnormal_liver_morphology | 1.05405118 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.04789164 |
| 37 | MP0003123_paternal_imprinting | 1.02167430 |
| 38 | MP0002078_abnormal_glucose_homeostasis | 1.02043333 |
| 39 | MP0001756_abnormal_urination | 1.01235745 |
| 40 | MP0003011_delayed_dark_adaptation | 0.98191582 |
| 41 | MP0002876_abnormal_thyroid_physiology | 0.97793111 |
| 42 | MP0003183_abnormal_peptide_metabolism | 0.97706421 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 0.92075349 |
| 44 | MP0009642_abnormal_blood_homeostasis | 0.91664870 |
| 45 | MP0005408_hypopigmentation | 0.91517425 |
| 46 | MP0009764_decreased_sensitivity_to | 0.90143998 |
| 47 | MP0002254_reproductive_system_inflammat | 0.87430652 |
| 48 | MP0000604_amyloidosis | 0.86784852 |
| 49 | MP0005647_abnormal_sex_gland | 0.86174702 |
| 50 | MP0010234_abnormal_vibrissa_follicle | 0.83944100 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 0.80335492 |
| 52 | MP0009763_increased_sensitivity_to | 0.79174165 |
| 53 | MP0008469_abnormal_protein_level | 0.78576135 |
| 54 | MP0005376_homeostasis/metabolism_phenot | 0.76666839 |
| 55 | MP0005448_abnormal_energy_balance | 0.76568953 |
| 56 | MP0009765_abnormal_xenobiotic_induced | 0.74441078 |
| 57 | MP0001984_abnormal_olfaction | 0.73722201 |
| 58 | MP0005670_abnormal_white_adipose | 0.73655767 |
| 59 | MP0003300_gastrointestinal_ulcer | 0.71711445 |
| 60 | MP0005535_abnormal_body_temperature | 0.71304452 |
| 61 | MP0005334_abnormal_fat_pad | 0.68146461 |
| 62 | MP0002089_abnormal_postnatal_growth/wei | 0.66485432 |
| 63 | MP0001765_abnormal_ion_homeostasis | 0.66014622 |
| 64 | MP0001944_abnormal_pancreas_morphology | 0.65878355 |
| 65 | MP0002928_abnormal_bile_duct | 0.65724512 |
| 66 | MP0002136_abnormal_kidney_physiology | 0.65257764 |
| 67 | MP0002132_abnormal_respiratory_system | 0.65163969 |
| 68 | MP0002822_catalepsy | 0.65139861 |
| 69 | MP0004270_analgesia | 0.64886643 |
| 70 | MP0002971_abnormal_brown_adipose | 0.63928674 |
| 71 | MP0002837_dystrophic_cardiac_calcinosis | 0.63730491 |
| 72 | MP0000003_abnormal_adipose_tissue | 0.62709322 |
| 73 | MP0005266_abnormal_metabolism | 0.61287648 |
| 74 | MP0000462_abnormal_digestive_system | 0.61063255 |
| 75 | MP0000538_abnormal_urinary_bladder | 0.60043194 |
| 76 | MP0003953_abnormal_hormone_level | 0.59403133 |
| 77 | MP0002090_abnormal_vision | 0.56890479 |
| 78 | MP0000516_abnormal_urinary_system | 0.56133904 |
| 79 | MP0005367_renal/urinary_system_phenotyp | 0.56133904 |
| 80 | MP0003718_maternal_effect | 0.55987191 |
| 81 | MP0009780_abnormal_chondrocyte_physiolo | 0.55955287 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 0.55578051 |
| 83 | MP0002693_abnormal_pancreas_physiology | 0.53911772 |
| 84 | MP0000639_abnormal_adrenal_gland | 0.51946563 |
| 85 | MP0009046_muscle_twitch | 0.51577251 |
| 86 | MP0003638_abnormal_response/metabolism_ | 0.50876912 |
| 87 | MP0005645_abnormal_hypothalamus_physiol | 0.50858365 |
| 88 | MP0000230_abnormal_systemic_arterial | 0.50301896 |
| 89 | MP0009053_abnormal_anal_canal | 0.50182816 |
| 90 | MP0005395_other_phenotype | 0.49071932 |
| 91 | MP0005646_abnormal_pituitary_gland | 0.48955478 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.47865859 |
| 93 | MP0005058_abnormal_lysosome_morphology | 0.47267933 |
| 94 | MP0001664_abnormal_digestion | 0.45936438 |
| 95 | MP0001661_extended_life_span | 0.45462782 |
| 96 | MP0005410_abnormal_fertilization | 0.44637641 |
| 97 | MP0010368_abnormal_lymphatic_system | 0.44330442 |
| 98 | MP0003329_amyloid_beta_deposits | 0.43707601 |
| 99 | MP0002796_impaired_skin_barrier | 0.42933700 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 0.42252817 |
| 101 | MP0008873_increased_physiological_sensi | 0.40198523 |
| 102 | MP0002163_abnormal_gland_morphology | 0.40014001 |
| 103 | MP0005666_abnormal_adipose_tissue | 0.39903721 |
| 104 | MP0003172_abnormal_lysosome_physiology | 0.39866803 |
| 105 | MP0004147_increased_porphyrin_level | 0.37661758 |
| 106 | MP0005248_abnormal_Harderian_gland | 0.36796396 |
| 107 | MP0008874_decreased_physiological_sensi | 0.36039925 |
| 108 | MP0005464_abnormal_platelet_physiology | 0.35873534 |
| 109 | MP0002069_abnormal_eating/drinking_beha | 0.35797075 |
| 110 | MP0004130_abnormal_muscle_cell | 0.35465100 |
| 111 | MP0005551_abnormal_eye_electrophysiolog | 0.34994858 |
| 112 | MP0010386_abnormal_urinary_bladder | 0.34811640 |
| 113 | MP0008872_abnormal_physiological_respon | 0.34662018 |
| 114 | MP0003941_abnormal_skin_development | 0.34535553 |
| 115 | MP0001501_abnormal_sleep_pattern | 0.33138118 |
| 116 | MP0000013_abnormal_adipose_tissue | 0.32736491 |
| 117 | MP0009115_abnormal_fat_cell | 0.32282358 |
| 118 | MP0003690_abnormal_glial_cell | 0.32204521 |
| 119 | MP0002909_abnormal_adrenal_gland | 0.31023087 |
| 120 | MP0005166_decreased_susceptibility_to | 0.30591325 |
| 121 | MP0005381_digestive/alimentary_phenotyp | 0.30508803 |
| 122 | MP0001845_abnormal_inflammatory_respons | 0.29959702 |
| 123 | MP0008961_abnormal_basal_metabolism | 0.28746257 |
| 124 | MP0009384_cardiac_valve_regurgitation | 0.26914518 |
| 125 | MP0003959_abnormal_lean_body | 0.26896247 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.21880105 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.54974424 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 6.36395835 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.20195855 |
| 5 | Deep venous thrombosis (HP:0002625) | 6.13886724 |
| 6 | Xanthomatosis (HP:0000991) | 5.83506715 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.75575983 |
| 8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.68741702 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.65488305 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.59617054 |
| 11 | Hypoglycemic coma (HP:0001325) | 4.53459863 |
| 12 | Hyperammonemia (HP:0001987) | 4.27883262 |
| 13 | Ketosis (HP:0001946) | 4.24915575 |
| 14 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22823800 |
| 15 | Complement deficiency (HP:0004431) | 4.20722212 |
| 16 | Conjugated hyperbilirubinemia (HP:0002908) | 4.18950736 |
| 17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.15927207 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.15133569 |
| 19 | Fat malabsorption (HP:0002630) | 4.14750256 |
| 20 | Epidermoid cyst (HP:0200040) | 4.09837672 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.07635510 |
| 22 | Hyperglycinuria (HP:0003108) | 4.07488723 |
| 23 | Joint hemorrhage (HP:0005261) | 4.01833418 |
| 24 | Hyperglycinemia (HP:0002154) | 3.97306808 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.92109963 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.82232588 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.82232588 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.80002232 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 3.73327701 |
| 30 | Ketoacidosis (HP:0001993) | 3.61463815 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.43606186 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.40719530 |
| 33 | Hypoglycemic seizures (HP:0002173) | 3.39050174 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.35288876 |
| 35 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.25729571 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.24189839 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.17913046 |
| 38 | Abnormality of purine metabolism (HP:0004352) | 3.14004784 |
| 39 | Gout (HP:0001997) | 3.11257961 |
| 40 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.08689491 |
| 41 | Abnormality of complement system (HP:0005339) | 3.04197058 |
| 42 | Acanthocytosis (HP:0001927) | 3.02548827 |
| 43 | Metabolic acidosis (HP:0001942) | 2.97213857 |
| 44 | Symptomatic seizures (HP:0011145) | 2.86511261 |
| 45 | Skin nodule (HP:0200036) | 2.82219581 |
| 46 | Late onset (HP:0003584) | 2.79886353 |
| 47 | Abnormal urine phosphate concentration (HP:0012599) | 2.77738869 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 2.74928650 |
| 49 | Malnutrition (HP:0004395) | 2.74546934 |
| 50 | Steatorrhea (HP:0002570) | 2.73409484 |
| 51 | Delayed CNS myelination (HP:0002188) | 2.72449939 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.68749137 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.68749137 |
| 54 | Hepatocellular carcinoma (HP:0001402) | 2.68074554 |
| 55 | Lethargy (HP:0001254) | 2.59140150 |
| 56 | Irritability (HP:0000737) | 2.56677310 |
| 57 | Abnormality of urine glucose concentration (HP:0011016) | 2.53328858 |
| 58 | Glycosuria (HP:0003076) | 2.53328858 |
| 59 | Generalized aminoaciduria (HP:0002909) | 2.52343511 |
| 60 | Abnormality of vitamin B metabolism (HP:0004340) | 2.50536833 |
| 61 | Hyperglycemia (HP:0003074) | 2.47253497 |
| 62 | Spontaneous abortion (HP:0005268) | 2.43886668 |
| 63 | Abnormality of proline metabolism (HP:0010907) | 2.43223606 |
| 64 | Hydroxyprolinuria (HP:0003080) | 2.43223606 |
| 65 | Vascular calcification (HP:0004934) | 2.39475330 |
| 66 | Nephritis (HP:0000123) | 2.38563672 |
| 67 | Abnormal gallbladder morphology (HP:0012437) | 2.38321419 |
| 68 | Gingival bleeding (HP:0000225) | 2.36041740 |
| 69 | Proximal tubulopathy (HP:0000114) | 2.34377619 |
| 70 | Facial shape deformation (HP:0011334) | 2.32804729 |
| 71 | Potter facies (HP:0002009) | 2.32804729 |
| 72 | Myocardial infarction (HP:0001658) | 2.29456403 |
| 73 | Systemic lupus erythematosus (HP:0002725) | 2.25964092 |
| 74 | Abnormality of vitamin metabolism (HP:0100508) | 2.24796338 |
| 75 | Hypophosphatemic rickets (HP:0004912) | 2.24434984 |
| 76 | Hypochromic microcytic anemia (HP:0004840) | 2.24391268 |
| 77 | Pancreatitis (HP:0001733) | 2.24244984 |
| 78 | Widely patent fontanelles and sutures (HP:0004492) | 2.22770743 |
| 79 | Cholelithiasis (HP:0001081) | 2.22634616 |
| 80 | Brushfield spots (HP:0001088) | 2.17967860 |
| 81 | Osteomalacia (HP:0002749) | 2.16471143 |
| 82 | Cerebral edema (HP:0002181) | 2.16051730 |
| 83 | Abnormal gallbladder physiology (HP:0012438) | 2.14863751 |
| 84 | Cholecystitis (HP:0001082) | 2.14863751 |
| 85 | Enlarged kidneys (HP:0000105) | 2.14844592 |
| 86 | Alkalosis (HP:0001948) | 2.14159529 |
| 87 | Poikilocytosis (HP:0004447) | 2.13724570 |
| 88 | Reduced antithrombin III activity (HP:0001976) | 2.12734803 |
| 89 | Hypothermia (HP:0002045) | 2.10516418 |
| 90 | Sensorimotor neuropathy (HP:0007141) | 2.10443718 |
| 91 | Cardiovascular calcification (HP:0011915) | 2.08457802 |
| 92 | Vomiting (HP:0002013) | 2.08077801 |
| 93 | Ileus (HP:0002595) | 2.07168148 |
| 94 | Glomerulonephritis (HP:0000099) | 2.06087189 |
| 95 | Hyperuricemia (HP:0002149) | 2.05299128 |
| 96 | Increased purine levels (HP:0004368) | 2.05299128 |
| 97 | Amyloidosis (HP:0011034) | 2.03939718 |
| 98 | Rickets (HP:0002748) | 2.03674213 |
| 99 | Acute encephalopathy (HP:0006846) | 2.00206591 |
| 100 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.99795348 |
| 101 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.99795348 |
| 102 | Esophageal varix (HP:0002040) | 1.99234429 |
| 103 | Spastic diplegia (HP:0001264) | 1.98666082 |
| 104 | Mitral stenosis (HP:0001718) | 1.96541601 |
| 105 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.95491611 |
| 106 | Abnormality of the gallbladder (HP:0005264) | 1.95424577 |
| 107 | Hyperphosphaturia (HP:0003109) | 1.94937777 |
| 108 | Hemorrhage of the eye (HP:0011885) | 1.94743115 |
| 109 | Menorrhagia (HP:0000132) | 1.94504897 |
| 110 | Hypotension (HP:0002615) | 1.91023310 |
| 111 | Hypophosphatemia (HP:0002148) | 1.90912958 |
| 112 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.90733406 |
| 113 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89703081 |
| 114 | Neonatal onset (HP:0003623) | 1.89462228 |
| 115 | Nephrolithiasis (HP:0000787) | 1.89364260 |
| 116 | Postural tremor (HP:0002174) | 1.89248441 |
| 117 | Increased serum pyruvate (HP:0003542) | 1.88909469 |
| 118 | Opisthotonus (HP:0002179) | 1.87962942 |
| 119 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.84386513 |
| 120 | Megaloblastic anemia (HP:0001889) | 1.82284621 |
| 121 | Abnormality of glycolysis (HP:0004366) | 1.81936975 |
| 122 | Renal tubular dysfunction (HP:0000124) | 1.81561299 |
| 123 | Mucopolysacchariduria (HP:0008155) | 1.77958689 |
| 124 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.77958689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.81986013 |
| 2 | MAP3K12 | 4.72651574 |
| 3 | FRK | 4.52713003 |
| 4 | INSRR | 4.51922048 |
| 5 | ERN1 | 4.38285585 |
| 6 | FGFR4 | 3.74882147 |
| 7 | SIK1 | 3.42099190 |
| 8 | MAP3K9 | 3.24777926 |
| 9 | TAOK3 | 3.22883497 |
| 10 | MST1R | 2.88521706 |
| 11 | MAPK15 | 2.76852137 |
| 12 | PIK3CG | 2.30605087 |
| 13 | FGFR3 | 2.30560020 |
| 14 | ACVR1B | 2.25738448 |
| 15 | SCYL2 | 2.21314090 |
| 16 | ERBB4 | 2.00778273 |
| 17 | PTK6 | 1.94732969 |
| 18 | TESK1 | 1.85327853 |
| 19 | AKT3 | 1.74744109 |
| 20 | FLT3 | 1.70700940 |
| 21 | WNK3 | 1.69823753 |
| 22 | NTRK3 | 1.53816256 |
| 23 | MAPK11 | 1.47173205 |
| 24 | LATS1 | 1.40038279 |
| 25 | GRK6 | 1.39115364 |
| 26 | MAP3K2 | 1.38889266 |
| 27 | MET | 1.38003944 |
| 28 | PKN2 | 1.36820347 |
| 29 | TRIB3 | 1.35352159 |
| 30 | STK38L | 1.34335056 |
| 31 | WNK4 | 1.31899131 |
| 32 | STK39 | 1.31699476 |
| 33 | IRAK3 | 1.29297767 |
| 34 | MAP2K4 | 1.29282967 |
| 35 | PRKG2 | 1.23692337 |
| 36 | ARAF | 1.23203418 |
| 37 | MAP2K2 | 1.20845960 |
| 38 | PAK4 | 1.20414340 |
| 39 | EPHA2 | 1.19361395 |
| 40 | DYRK1B | 1.18179132 |
| 41 | MAP3K3 | 1.12721432 |
| 42 | CAMK2D | 1.12069115 |
| 43 | PRKAA2 | 1.10442389 |
| 44 | TYK2 | 1.08848269 |
| 45 | PTK2 | 1.05287111 |
| 46 | PHKG1 | 1.04551618 |
| 47 | PHKG2 | 1.04551618 |
| 48 | RIPK1 | 1.03793263 |
| 49 | CSNK1G1 | 1.03104605 |
| 50 | LIMK1 | 0.99725917 |
| 51 | LMTK2 | 0.97585719 |
| 52 | JAK2 | 0.96785420 |
| 53 | CASK | 0.96014636 |
| 54 | PRKCI | 0.93532467 |
| 55 | DAPK1 | 0.93270846 |
| 56 | EIF2AK1 | 0.92159808 |
| 57 | PRKCE | 0.91135803 |
| 58 | DAPK2 | 0.90529864 |
| 59 | PRKAA1 | 0.90027000 |
| 60 | MAP3K11 | 0.88587882 |
| 61 | MAP3K10 | 0.88194416 |
| 62 | OXSR1 | 0.87729601 |
| 63 | CSNK1G3 | 0.87197679 |
| 64 | PINK1 | 0.84595626 |
| 65 | MUSK | 0.82926525 |
| 66 | ERBB2 | 0.80978311 |
| 67 | MAP2K6 | 0.78595903 |
| 68 | GRK5 | 0.76038481 |
| 69 | TAOK1 | 0.75034428 |
| 70 | NUAK1 | 0.74444225 |
| 71 | PBK | 0.74122036 |
| 72 | ABL2 | 0.74035978 |
| 73 | JAK1 | 0.70135672 |
| 74 | PAK3 | 0.69658596 |
| 75 | PRKACG | 0.68513552 |
| 76 | PRKCZ | 0.67544706 |
| 77 | NLK | 0.66417074 |
| 78 | TRPM7 | 0.65638083 |
| 79 | CAMK2G | 0.65588894 |
| 80 | NEK9 | 0.65252833 |
| 81 | PDPK1 | 0.64852784 |
| 82 | PRKG1 | 0.64668574 |
| 83 | TBK1 | 0.64483652 |
| 84 | MAP3K7 | 0.64380662 |
| 85 | MAP3K1 | 0.64305536 |
| 86 | TNK2 | 0.63553529 |
| 87 | CSNK1E | 0.60944586 |
| 88 | GSK3A | 0.60613004 |
| 89 | EPHB1 | 0.60189284 |
| 90 | KDR | 0.60108165 |
| 91 | PASK | 0.59808687 |
| 92 | NEK1 | 0.59257549 |
| 93 | CSK | 0.58920606 |
| 94 | TNIK | 0.58563816 |
| 95 | CSNK1G2 | 0.58235772 |
| 96 | GRK1 | 0.54110950 |
| 97 | RPS6KB2 | 0.53411448 |
| 98 | EPHA3 | 0.53175455 |
| 99 | MAP2K1 | 0.52706507 |
| 100 | MST4 | 0.51970493 |
| 101 | ZAK | 0.49996070 |
| 102 | PDK2 | 0.48156436 |
| 103 | MAPK4 | 0.47902657 |
| 104 | CDK6 | 0.47876789 |
| 105 | CSNK1D | 0.47481125 |
| 106 | STK16 | 0.46837362 |
| 107 | CSNK1A1L | 0.46427164 |
| 108 | CSNK2A2 | 0.45917450 |
| 109 | STK38 | 0.44636638 |
| 110 | FGFR1 | 0.44498620 |
| 111 | MAP3K4 | 0.43798732 |
| 112 | TTK | 0.43330866 |
| 113 | FER | 0.42416657 |
| 114 | AKT2 | 0.41401696 |
| 115 | SGK3 | 0.40882692 |
| 116 | MAP4K2 | 0.39925098 |
| 117 | CAMK2B | 0.39737539 |
| 118 | MAP2K3 | 0.38714082 |
| 119 | STK3 | 0.38582595 |
| 120 | PDK1 | 0.36343471 |
| 121 | FGFR2 | 0.34973553 |
| 122 | PRKCQ | 0.34404202 |
| 123 | PRKCA | 0.34392018 |
| 124 | EIF2AK3 | 0.31618837 |
| 125 | MTOR | 0.30720862 |
| 126 | IGF1R | 0.30660081 |
| 127 | HIPK2 | 0.28981997 |
| 128 | MYLK | 0.28764858 |
| 129 | SGK223 | 0.28686136 |
| 130 | SGK494 | 0.28686136 |
| 131 | MAP3K14 | 0.28621677 |
| 132 | PDK3 | 0.27969342 |
| 133 | PDK4 | 0.27969342 |
| 134 | MAP3K5 | 0.25833297 |
| 135 | PIK3CA | 0.24970885 |
| 136 | ITK | 0.24390626 |
| 137 | SGK2 | 0.23268266 |
| 138 | TESK2 | 0.23237364 |
| 139 | PDGFRA | 0.22561671 |
| 140 | IRAK1 | 0.21498011 |
| 141 | TIE1 | 0.20746272 |
| 142 | EPHB2 | 0.20425833 |
| 143 | CAMK1D | 0.17421111 |
| 144 | RET | 0.17128501 |
| 145 | PRKACA | 0.16419024 |
| 146 | MAPKAPK3 | 0.16332880 |
| 147 | PRKCG | 0.16152631 |
| 148 | CSNK1A1 | 0.15242956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.95231532 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.32361491 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.25059136 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.01087880 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.88371797 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73783094 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48277943 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.46170548 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34290762 |
| 10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.33105111 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.32585343 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.32433418 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.27434491 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26401708 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14256488 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.04834668 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.03494396 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.01354698 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.99580486 |
| 20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.97672496 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84077188 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.76737463 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76581429 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75440896 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.75118490 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.71859091 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.71751380 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71339017 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.69523816 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68891537 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.62428822 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.61395289 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58397482 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.57849701 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56082511 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.54971214 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.52559131 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52447508 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49240959 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.47825970 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45089909 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.39850318 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.28326163 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28037626 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.25538232 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21724363 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15852613 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11554171 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11445958 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10513500 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08649335 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07945756 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07592315 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01018379 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93554586 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91145628 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88168515 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87596309 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.81367672 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80565396 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80531707 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77228009 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75208251 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74753766 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70938108 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65958777 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65382018 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53260568 |
| 69 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51624094 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51116847 |
| 71 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50330562 |
| 72 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.48587725 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38758978 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38350039 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35489091 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.35108532 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32781974 |
| 78 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32712411 |
| 79 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32147122 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28285237 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.25984106 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.23300865 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.20605453 |
| 84 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.20439796 |
| 85 | Protein export_Homo sapiens_hsa03060 | 0.18446865 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.16417897 |
| 87 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.15229463 |
| 88 | Parkinsons disease_Homo sapiens_hsa05012 | 0.14171536 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.13600523 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13074479 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.12458134 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11289784 |
| 93 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.10764690 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.10539648 |
| 95 | Alzheimers disease_Homo sapiens_hsa05010 | 0.10367301 |
| 96 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.06133991 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.04427450 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01073995 |
| 99 | Lysosome_Homo sapiens_hsa04142 | -0.1618859 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1519355 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | -0.1367390 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1302605 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1189326 |
| 104 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1178988 |
| 105 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1141696 |
| 106 | Insulin secretion_Homo sapiens_hsa04911 | -0.1133805 |
| 107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0686120 |
| 108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0663842 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0655713 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0115161 |

